Patents by Inventor Kevin Freeman

Kevin Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10884138
    Abstract: A satellite Automatic Identification System (AIS) for tracking maritime vessels includes a constellation of Low-Earth Orbit (LEO) satellites. Each LEO satellite includes an AIS payload for receiving AIS messages from the maritime vessels and determining therefrom reported vessel position data and satellite-based observation data. The system also includes an AIS reporting system configured to obtain the reported maritime vessel position data and satellite-based observation data from the LEO satellites over time. In addition, the AIS reporting system is configured to filter the reported maritime vessel position data and satellite-based observation data to recursively produce estimated maritime vessel positions and update the estimated maritime vessel positions for the maritime vessels.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: January 5, 2021
    Assignee: EAGLE TECHNOLOGY, LLC
    Inventors: Kenneth Joseph Ernandes, Sean Kevin Freeman
  • Publication number: 20200236079
    Abstract: Examples relate to a method, an apparatus and a computer program for processing a plurality of electronic messages, and to an electronic message server. The method comprises obtaining (110) the plurality of electronic messages. The method further comprises selecting (120) at least a subset of electronic messages of the plurality of electronic messages based on information related to a plurality of suspicious electronic message sender identifiers. The method further comprises determining (130), whether a number of electronic messages of the subset of electronic messages obtained within a pre-defined time interval exceeds a threshold. The method further comprises discarding (140) the electronic messages of the subset of electronic messages if the number of electronic messages of the subset of electronic messages obtained within the pre-defined time interval exceeds the threshold.
    Type: Application
    Filed: January 18, 2019
    Publication date: July 23, 2020
    Inventors: Haya SHULMAN, Kevin FREEMAN, Markus SCHNEIDER
  • Publication number: 20190391277
    Abstract: A satellite Automatic Identification System (AIS) for tracking maritime vessels includes a constellation of Low-Earth Orbit (LEO) satellites. Each LEO satellite includes an AIS payload for receiving AIS messages from the maritime vessels and determining therefrom reported vessel position data and satellite-based observation data. The system also includes an AIS reporting system configured to obtain the reported maritime vessel position data and satellite-based observation data from the LEO satellites over time. In addition, the AIS reporting system is configured to filter the reported maritime vessel position data and satellite-based observation data to recursively produce estimated maritime vessel positions and update the estimated maritime vessel positions for the maritime vessels.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 26, 2019
    Inventors: Kenneth Joseph ERNANDES, Sean Kevin Freeman
  • Publication number: 20160022708
    Abstract: Provided herein are methods for a novel combination therapy for treating a glutamine-addicted cancer in a subject in need thereof, which comprises the administration of a glutaminase antagonist and a pro-apoptotic compound. Specific glutaminase antagonists and pro-apoptotic compounds are provided. In some embodiments, the glutaminase antagonist is 6-diazo-5-oxo-1-norleucine (DON) and the pro-apoptotic compound is a Bcl-2 family member antagonist. In some embodiments, the pro-apoptotic compound is obatoclax mesylate, navitoclax, or fenretinide. In some embodiments, the glutamine-addicted cancer is a cancer in which Myc is deregulated. In some embodiments, the cancer is a pediatric cancer.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Applicant: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
    Inventor: Kevin Freeman
  • Patent number: 9038056
    Abstract: A method, apparatus and computer program product for performing automatic enterprise software upgrades is presented. An install agent application of a target system authorizes a centralized controller to securely communicate with the target system. The install agent downloads an upgrade for an enterprise software application installed on said target system from the centralized controller and executes the upgrade for an enterprise software application installed on the target system.
    Type: Grant
    Filed: March 8, 2010
    Date of Patent: May 19, 2015
    Assignee: AVAYA INC.
    Inventors: Jeffrey Wong, Kevin Freeman, Catherine Howe, Wayne Wong, Bill McCarty
  • Patent number: 8318762
    Abstract: The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: November 27, 2012
    Assignee: Pfizer Inc.
    Inventors: Jeffrey W. Corbett, Richard Elliott, Kevin Freeman-Cook, David A. Griffith, Dennis P. Phillion
  • Publication number: 20110028390
    Abstract: The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: May 18, 2009
    Publication date: February 3, 2011
    Applicant: PFIZER, INC.
    Inventors: Jeffrey W. Corbett, Richard Elliott, Kevin Freeman-Cook, David A. Griffith, Dennis P. Phillion
  • Publication number: 20080051419
    Abstract: The invention relates to compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein: A is a moiety of formula: and to pharmaceutically acceptable salts and solvates thereof, wherein X, Z, D, E, V, W, Y, R1, R2, R5, R6, L, and u are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula I to a patient in need thereof, and to compositions for treating such disorders which contain the compounds of formula I. The invention also relates to methods of making the compounds of formula I.
    Type: Application
    Filed: July 20, 2007
    Publication date: February 28, 2008
    Inventors: Matthew Corbett, Kevin Freeman-Cook, Goss Kauffman, Blaise Lippa, Michael Luzzio, Joel Morris
  • Patent number: 6900201
    Abstract: The present invention relates to N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula wherein ring X is a 5-7 membered heterocyclic ring, and wherein A, Y, B, and G are as defined in the specification; and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: May 31, 2005
    Assignee: Pfizer Inc.
    Inventors: Mark C. Noe, Kevin Freeman-Cook
  • Publication number: 20040010141
    Abstract: The present invention relates to N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula 1
    Type: Application
    Filed: April 25, 2003
    Publication date: January 15, 2004
    Applicant: Pfizer Inc.
    Inventors: Mark C. Noe, Kevin Freeman-Cook